The role of regional chemotherapy in the management of extremity soft tissue malignancies

被引：10

作者：

Smith, H. G. ^{[1
]}

Hayes, A. J. ^{[1
]}

机构：

[1] Royal Marsden Hosp NHS Fdn Trust, Sarcoma & Melanoma Unit, Acad Dept Surg, London, England

来源：

EJSO | 2016年 / 42卷 / 01期

关键词：

Isolated limb perfusion; Isolated limb infusion; In-transit melanoma; Soft tissue sarcoma; ISOLATED LIMB PERFUSION; TUMOR-NECROSIS-FACTOR; MERKEL CELL-CARCINOMA; TERM-FOLLOW-UP; FACTOR-ALPHA; INTERFERON-GAMMA; ADVANCED MELANOMA; PHASE-I; INTRAARTERIAL TEMOZOLOMIDE; HYPERTHERMIC PERFUSION;

D O I：

10.1016/j.ejso.2015.08.165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Regional chemotherapy involves the targeted delivery of high dose chemotherapy to an affected area. In the limbs, the two main methods employed are isolated limb perfusion (ILP) and isolated limb infusion (ILI), with advantages and disadvantages to each technique. The aim of this review was to clarify the roles of each technique in the management of locally advanced soft tissue malignancies of the extremities. Methods: Relevant articles were identified from a comprehensive literature search using the PubMed database. Keywords included isolated limb perfusion, isolated limb infusion, in-transit melanoma and sarcoma. No restrictions on publication date were used. Results: Regional chemotherapy may be used to secure local control in a range of soft tissue malignancies not amenable to standard excision and is increasingly used as an induction treatment in soft tissue sarcoma. Though both ILI and ILP are well established in the management of in-transit melanoma, ILP should be preferentially used in soft tissue sarcoma. Conclusion: Regional chemotherapy is an effective treatment for locally advanced extremity malignancies and the technique used should be tailored to patient and tumour factors. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：7 / 17

页数：11

共 92 条

[1]

ABBRUZZESE JL, 1989, CANCER RES, V49, P4057

[2] Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters [J].

Alexander, H. Richard, Jr. ;

Fraker, Douglas L. ;

Bartlett, David L. ;

Libutti, Steven K. ;

Steinberg, Seth M. ;

Soriano, Perry ;

Beresnev, Tatiana .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :114-118

[3] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].

Andtbacka, Robert H. I. ;

Kaufman, Howard L. ;

Collichio, Frances ;

Amatruda, Thomas ;

Senzer, Neil ;

Chesney, Jason ;

Delman, Keith A. ;

Spitler, Lynn E. ;

Puzanov, Igor ;

Agarwala, Sanjiv S. ;

Milhem, Mohammed ;

Cranmer, Lee ;

Curti, Brendan ;

Lewis, Karl ;

Ross, Merrick ;

Guthrie, Troy ;

Linette, Gerald P. ;

Daniels, Gregory A. ;

Harrington, Kevin ;

Middleton, Mark R. ;

Miller, Wilson H., Jr. ;

Zager, Jonathan S. ;

Ye, Yining ;

Yao, Bin ;

Li, Ai ;

Doleman, Susan ;

VanderWalde, Ari ;

Gansert, Jennifer ;

Coffin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98

[4]

[Anonymous], 2009, J AM COLL SURGEONS

[5] Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities - Long-term follow-up of a randomised trial [J].

Bagge, Roger Olofsson ;

Mattsson, Jan ;

Hafstrom, Lo .

INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2014, 30 (05) :295-298

[6] Final Version of 2009 AJCC Melanoma Staging and Classification [J].

Balch, Charles M. ;

Gershenwald, Jeffrey E. ;

Soong, Seng-jaw ;

Thompson, John F. ;

Atkins, Michael B. ;

Byrd, David R. ;

Buzaid, Antonio C. ;

Cochran, Alistair J. ;

Coit, Daniel G. ;

Ding, Shouluan ;

Eggermont, Alexander M. ;

Flaherty, Keith T. ;

Gimotty, Phyllis A. ;

Kirkwood, John M. ;

McMasters, Kelly M. ;

Mihm, Martin C., Jr. ;

Morton, Donald L. ;

Ross, Merrick I. ;

Sober, Arthur J. ;

Sondak, Vernon K. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206

[7]

BALKWILL FR, 1986, CANCER RES, V46, P3990

[8] A Multicenter Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion [J].

Beasley, Georgia M. ;

Speicher, Paul ;

Augustine, Christina K. ;

Dolber, Paul C. ;

Peterson, Bercedis L. ;

Sharma, Ketan ;

Mosca, Paul J. ;

Royal, Richard ;

Ross, Merrick ;

Zager, Jonathan S. ;

Tyler, Douglas S. .

ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (01) :287-294

[9] A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US [J].

Beasley, Georgia M. ;

Caudle, Abigail ;

Petersen, Rebecca P. ;

McMahon, Nicole S. ;

Padussis, James ;

Mosca, Paul J. ;

Zager, Jonathan S. ;

Hochwald, Steven N. ;

Grobmyer, Stephen R. ;

Delman, Keith A. ;

Andtbacka, Robert H. ;

Noyes, R. Dirk ;

Kane, John M. ;

Seigler, Hilliard ;

Pruitt, Scott K. ;

Ross, Merrick I. ;

Tyler, Douglas S. .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (05) :706-715

[10] Merkel Cell Carcinoma, Version 1.2014 [J].

Bichakjian, Christopher K. ;

Olencki, Thomas ;

Alam, Murad ;

Andersen, James S. ;

Berg, Daniel ;

Bowen, Glen M. ;

Cheney, Richard T. ;

Daniels, Gregory A. ;

Glass, L. Frank ;

Grekin, Roy C. ;

Grossman, Kenneth ;

Ho, Alan L. ;

Lewis, Karl D. ;

Lydiatt, Daniel D. ;

Morrison, William H. ;

Nehal, Kishwer S. ;

Nelson, Kelly C. ;

Nghiem, Paul ;

Perlis, Clifford S. ;

Shaha, Ashok R. ;

Thorstad, Wade L. ;

Tuli, Malika ;

Urist, Marshall M. ;

Wang, Timothy S. ;

Werchniak, Andrew E. ;

Wong, Sandra L. ;

Zic, John A. ;

Hoffmann, Karin G. ;

McMillian, Nicole R. ;

Ho, Maria .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (03) :410-424

← 1 2 3 4 5 6 7 8 9 10 →